The Company offers a single, comprehensive platform to support all telehealth needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. Amwell believes that digital care delivery will transform healthcare. Together, we are reimagining how care is delivered – shifting from reactive to proactive, episodic to continuous, and hospital to home – to improve outcomes and experience for both patients and for providers.”Īmwell is a leading telehealth platform in the United States and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. “Now, as part of Amwell, we are accelerating our vision to power the healthcare delivery model of the future – one in which physical, virtual, and automated interactions are orchestrated using data to optimize care delivery. “Leading healthcare organizations are using our automated care programs to enhance care quality, access and experience, while driving better health outcomes,” said Murray Brozinsky, CEO of Conversa Health. Seamlessly integrating Conversa now enables us to drive important cultural, operational and go to market initiatives as one company, bolstering our overall differentiation with advanced, coordinated care programs, and amplifying our ability to deliver on our vision for digital first care delivery.” “It was evident from the start that Conversa is a great strategic fit for Amwell. Ido Schoenberg, Chairman and CEO, Amwell. Working as one team with Conversa, we are able to offer our clients a unique, fully integrated, yet comprehensive and highly scalable, end-to-end digital care delivery enterprise platform that enables the digital orchestration of physical, virtual and automated care,” said Dr. “While we were planning to measure the earnout at the end of 2022, the benefits of full integration now are meaningful. As a result of this renegotiation, Amwell issued an aggregate of 1,020,964 shares of the Company’s Class A common stock to the former stockholders of Conversa Health. This change further allows Amwell to accelerate the integration and alignment of Conversa in support of new product development, cross-selling opportunities, and operational efficiencies. BOSTON-( BUSINESS WIRE)- Amwell® (NYSE: AMWL), a leading enterprise software company enabling digital delivery of care for healthcare’s key stakeholders, today announced that it has reached an agreement to shorten the earnout period associated with its acquisition of Conversa Health, the automated care company it purchased in August, 2021.
0 Comments
Leave a Reply. |